Bivirkninger set i placebokontrollerede osteoporose- studier med en højere hyppighed hos Fablyn- behandlede end hos placebobehandlede kvinder
Adverse reactions observed in placebo-controlled osteoporosis treatment clinical trials in more FABLYN-treated women than in placebo-treated women